[ Le carcinosarcome ovarien: A propos d’un cas ]
Volume 30, Issue 1, July 2020, Pages 288–294
J. Meddah1, C. Mohammadine2, F. Tijami3, and H. Hachi4
1 Service de gynécologie obstétrique cancérologie et grossesse à haut risque, Maternité Souissi, Université Mohamed V, Rabat, Morocco
2 Service de Gynécologie-Obstétrique, de Cancérologie et de Grossesses à Haut Risque, CHU Ibn Sina, Rabat, Morocco
3 Pole gynéco-mammaire, Institut national d’oncologie Université Mohammed V Souissi, Rabat, Morocco
4 Pole gynéco-mammaire, Institut national d’oncologie Université Mohammed V Souissi, Rabat, Morocco
Original language: French
Copyright © 2020 ISSR Journals. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Ovarian carcinosarcoma is a rare malignant gynecological tumor that accounts for about 1% of all ovarian cancers. The positive diagnosis of this disease is based on clinical examination, radiological examinations and essentially histological confirmation: the association of a carcinomatous component with a sarcomatous component. Generally, the treatment performed is surgical cytoreduction, followed by chemotherapy and/or radiotherapy. As the prognosis is poor, the survival rate will depend mainly on the quality of surgical management.Multicenter or multinational studies, based on genetic and molecular signaling pathways, are required to better understand this tumor subtype and compare its treatment modalities.
Author Keywords: Ovarian carcinosarcoma, rare cancer, poor prognosis, surgical reduction, chemotherapy.
Volume 30, Issue 1, July 2020, Pages 288–294
J. Meddah1, C. Mohammadine2, F. Tijami3, and H. Hachi4
1 Service de gynécologie obstétrique cancérologie et grossesse à haut risque, Maternité Souissi, Université Mohamed V, Rabat, Morocco
2 Service de Gynécologie-Obstétrique, de Cancérologie et de Grossesses à Haut Risque, CHU Ibn Sina, Rabat, Morocco
3 Pole gynéco-mammaire, Institut national d’oncologie Université Mohammed V Souissi, Rabat, Morocco
4 Pole gynéco-mammaire, Institut national d’oncologie Université Mohammed V Souissi, Rabat, Morocco
Original language: French
Copyright © 2020 ISSR Journals. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Ovarian carcinosarcoma is a rare malignant gynecological tumor that accounts for about 1% of all ovarian cancers. The positive diagnosis of this disease is based on clinical examination, radiological examinations and essentially histological confirmation: the association of a carcinomatous component with a sarcomatous component. Generally, the treatment performed is surgical cytoreduction, followed by chemotherapy and/or radiotherapy. As the prognosis is poor, the survival rate will depend mainly on the quality of surgical management.Multicenter or multinational studies, based on genetic and molecular signaling pathways, are required to better understand this tumor subtype and compare its treatment modalities.
Author Keywords: Ovarian carcinosarcoma, rare cancer, poor prognosis, surgical reduction, chemotherapy.
Abstract: (french)
Le carcinosarcome ovarien est une tumeur gynécologique maligne rare qui représente environ 1% de l’ensemble des cancers ovariens. Le diagnostic positif de cette maladie repose sur l’examen clinique, les examens radiologiques et essentiellement la confirmation histologique : l’association d’une composante carcinomateuse à une composante sarcomateuse. Généralement, le traitement réalisé est la cytoréduction chirurgicale, suivie d’une chimiothérapie et/ou d’une radiothérapie. Le pronostic étant sombre, le taux de survie dépendra essentiellement de la qualité de la prise en charge chirurgicale.Des études multicentriques ou multinationales, basés sur les voies de signalisation génétique et moléculaire, sont requises afin de mieux comprendre ce sous-type de tumeur et de comparer ses modalités de traitement.
Author Keywords: Carcinosarcome ovarien, cancer rare, pronostic sombre, réduction chirurgicale, chimiothérapie.
How to Cite this Article
J. Meddah, C. Mohammadine, F. Tijami, and H. Hachi, “Carcinosarcoma of the ovary: A case report,” International Journal of Innovation and Applied Studies, vol. 30, no. 1, pp. 288–294, July 2020.
